Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3145 results found
Expand All
Apply All
3145 results found

BIO Comments to HHS Centers for Medicare & Medicaid Services’ Draft CY 2025 Part D Redesign Program Instructions
Share
Letters, Testimony & Comments  •  March 1, 2024
We are writing on behalf of the Biotechnology Innovation Organization (BIO) to provide comments on the Centers for Medicare & Medicaid Services’ Draft CY 2025 Part D Redesign Program Instructions.
Read More

BIO Comments to HHS on Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (Docket CMS-2024-0006)
Share
Letters, Testimony & Comments  •  March 1, 2024
CMS proposes updates to the RxHCC to reflect the impact of the new 2025 Part D benefit structure per the Inflation Reduction Act (IRA).
Read More

Rare Disease Day and BIO CEO recaps
Share
Good Day BIO Newsletter  •  March 1, 2024
Happy March. We recap yesterday’s Rare Disease Day hearing—and the bipartisan support for a few key BIO priorities—and look at a few things you might have missed at the BIO CEO and Investor Conference. (552 words, 2 minutes, 45 seconds)
Read More

BIO Office Hours: Monetizing the R&D Tax Credit (Day 2)
Share
February 29, 2024
Life science companies generate a significant portion of the annual R&D tax credits claimed every year. Yet, the majority of startups and small-to-midsize businesses do not take advantage of federal, state, and local tax credits. ADP Tax Credit experts will hold 20 minute virtual appointments to answer your questions on the federal tax credit and help determine the likelihood of your company qualifying for the tax credit. What to expect in the overview & 20-minute Zoom session: Federal R&D credit overview and ways to monetize the credit Eligible costs and requirements to qualify Examples of qualifying activities in the Biotech industry State R&D credits R&D project lifecycle
Read More

What to watch on Rare Disease Day
Share
Good Day BIO Newsletter  •  February 29, 2024
A leap year means we have an extra day in the month to talk about rare disease patients and R&D. Plus, Agriculture Secretary Tom Vilsack talked about biotech on the Hill and BIO’s David Thomas writes about the vaccine pipeline in International Business Times. (849 words, 4 minutes, 19 seconds)
Read More

BIO Office Hours: Monetizing the R&D Tax Credit (Day 1)
Share
February 28, 2024
Life science companies generate a significant portion of the annual R&D tax credits claimed every year. Yet, the majority of startups and small-to-midsize businesses do not take advantage of federal, state, and local tax credits. ADP Tax Credit experts will hold 20 minute virtual appointments to answer your questions on the federal tax credit and help determine the likelihood of your company qualifying for the tax credit. What to expect in the overview & 20-minute Zoom session: Federal R&D credit overview and ways to monetize the credit Eligible costs and requirements to qualify Examples of qualifying activities in the Biotech industry State R&D credits R&D project lifecycle
Read More

Technology Transfer
Share
Policy

CEOs to Congress: Pass ORPHAN Cures Act
Share
Good Day BIO Newsletter  •  February 28, 2024
BIO members and CEOs sent a letter to congressional leaders urging them to pass the ORPHAN Cures Act and support rare disease R&D. Plus, more highlights from the BIO CEO and Investor Conference, including what executives are saying about the policy outlook and AI. (676 words, 3 minutes, 22 seconds)
Read More

BIO CEO & Investor Conference (Day 2)
Share
February 27, 2024
Participate in the BIO CEO & Investor Conference, one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. Don't miss your opportunity to: Find and request meetings with potential partners using the BIO One-on-One Partnering™ system Discover the latest innovations in biotech during Company Presentations Hear from thought-leaders during sessions on therapeutic advancements, market outlook, and policy priorities Past speakers include MDs, CSOs and industry analysts discussing the latest information on pipeline innovation along with industry executives and analysts who delve into timely and relevant business models, deal-making, and investment trends. Download the 2023 Program Guide to see the caliber of sessions you can expect at the event.
Read More

I am BIO Podcast (Old)
Share

Pagination

  • First First page
  • Prev Previous page
  • …
  • 61
  • 62
  • 63
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO